Vaccine composition
US7767658B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 9, 2008 |
| Grant date | Aug 3, 2010 |
| Priority date | — |
| Expiry date | Jan 15, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition comprising at least one vaccine antigen, which also comprises at least one phosphoric ester derivative of phosphatidylcholine having the structure:in which:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.